Synexa Life Sciences celebrates its 20th anniversary
Synexa Life Sciences celebrates its 20th anniversary
Two decades of advancing drug development programs through specialist biomarker and bioanalytical insights.
Synexa Life Sciences to appoint Chief Commercial Officer to support company growth ambitions
Synexa Life Sciences to appoint Chief Commercial Officer to support company growth ambitions
Leading specialist biomarker and bioanalysis solutions provider further strengthens global management team.
Synexa Life Sciences expands operations in North America with new Rockville laboratory site
Synexa Life Sciences expands operations in North America with new Rockville laboratory site
New site supports unique and seamless workflows that narrow the gap between preclinical and clinical phases
Synexa Life Sciences acquires Finnish CRO Syrinx Bioanalytics to expand bioanalysis capabilities
Synexa Life Sciences acquires Finnish CRO Syrinx Bioanalytics to expand bioanalysis capabilities
Expansion of leading biomarker and bioanalysis company enhances bioanalytical solutions for targeted radiopharmaceuticals.
Synexa Life Sciences announces strategic growth plans and strengthening of its executive team
Synexa Life Sciences announces strategic growth plans and strengthening of its executive team
Delivering on growth strategies to become the global market leader in specialist biomarker and bioanalytical services.
Synexa Life Sciences Co-founder and CEO to become company’s Chairman
Synexa Life Sciences Co-founder and CEO to become company’s Chairman
Leading biomarker and bioanalysis company lays the foundation for future growth and expansion plan.
Synexa Announces Tripartite Collaboration
Synexa Announces Tripartite Collaboration
Together with Paraxel and Drawbridge Health, Synexa offers a streamlined solution to COVID-19 serology testing.
